Stylli lands CEO post at Sequenom

Harry Stylli, former CEO at Xencor, will take over as CEO of Sequenom. Stylli remains a director of Xencor and is the founder of Aurora Biosciences. He replaces Antonius Schuh, who resigned in February. Company CFO Stephen Zaniboni has been acting CEO in the interim.

- read this story from Marketwatch on the appointment

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.